BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
63.12
+0.56 (0.90%)
Nov 21, 2024, 2:14 PM EST - Market open
BioMarin Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 12,043 | 18,162 | 19,234 | 16,220 | 15,918 | 15,187 | Upgrade
|
| Market Cap Growth | -19.63% | -5.57% | 18.58% | 1.90% | 4.81% | 0.17% | Upgrade
|
| Enterprise Value | 11,595 | 18,132 | 19,051 | 16,229 | 15,917 | 15,375 | Upgrade
|
| Last Close Price | 62.56 | 96.42 | 103.49 | 88.35 | 87.69 | 84.55 | Upgrade
|
| PE Ratio | 37.70 | 110.83 | 137.99 | - | 19.49 | - | Upgrade
|
| Forward PE | 17.65 | 38.98 | 39.00 | 85.79 | 75.56 | 59.78 | Upgrade
|
| PS Ratio | 4.31 | 7.51 | 9.18 | 8.79 | 8.56 | 8.91 | Upgrade
|
| PB Ratio | 2.20 | 3.67 | 4.18 | 3.80 | 3.88 | 4.86 | Upgrade
|
| P/TBV Ratio | 2.70 | 4.10 | 4.73 | 4.41 | 4.56 | 6.15 | Upgrade
|
| P/FCF Ratio | 37.27 | 290.28 | 350.06 | 77.63 | - | - | Upgrade
|
| P/OCF Ratio | 28.75 | 114.04 | 109.34 | 53.26 | 186.47 | 314.68 | Upgrade
|
| PEG Ratio | 0.70 | 1.07 | 0.86 | 2.66 | 1.75 | 0.96 | Upgrade
|
| EV/Sales Ratio | 4.21 | 7.49 | 9.09 | 8.79 | 8.56 | 9.02 | Upgrade
|
| EV/EBITDA Ratio | 27.21 | 65.58 | 111.45 | 481.22 | 1186.81 | 34707.47 | Upgrade
|
| EV/EBIT Ratio | 35.52 | 105.36 | 276.25 | - | - | - | Upgrade
|
| EV/FCF Ratio | 36.25 | 289.80 | 346.74 | 77.67 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.23 | 0.24 | 0.26 | 0.28 | 0.29 | Upgrade
|
| Debt / EBITDA Ratio | 1.37 | 3.90 | 6.07 | 23.56 | 43.10 | 67.53 | Upgrade
|
| Debt / FCF Ratio | 1.88 | 18.12 | 20.38 | 5.38 | - | - | Upgrade
|
| Asset Turnover | 0.40 | 0.37 | 0.34 | 0.31 | 0.35 | 0.37 | Upgrade
|
| Inventory Turnover | 1.19 | 1.26 | 1.36 | 1.49 | 1.67 | 1.77 | Upgrade
|
| Quick Ratio | 2.39 | 1.45 | 2.98 | 2.54 | 3.07 | 1.21 | Upgrade
|
| Current Ratio | 4.27 | 2.51 | 4.67 | 4.16 | 4.76 | 2.08 | Upgrade
|
| Return on Equity (ROE) | 6.25% | 3.51% | 3.19% | -1.53% | 23.63% | -0.78% | Upgrade
|
| Return on Assets (ROA) | 3.00% | 1.63% | 0.70% | -0.78% | -1.09% | -1.44% | Upgrade
|
| Return on Capital (ROIC) | 3.40% | 1.82% | 0.78% | -0.87% | -1.24% | -1.67% | Upgrade
|
| Earnings Yield | 2.70% | 0.92% | 0.74% | -0.40% | 5.37% | -0.16% | Upgrade
|
| FCF Yield | 2.68% | 0.34% | 0.29% | 1.29% | -0.18% | -0.64% | Upgrade
|
| Buyback Yield / Dilution | -0.93% | -1.39% | -3.34% | 4.60% | -7.06% | -1.00% | Upgrade
|
| Total Shareholder Return | -0.93% | -1.39% | -3.34% | 4.60% | -7.06% | -1.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.